Cajanus extracts and glucosamine for inflammatory disorders
OwnerDaniel Raederstorff, Nathalie Richard +3inventors
InventorsDaniel Raederstorff, Nathalie Richard, Joseph Schwager, Christof Wehrli, Swen Wolfram
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel compositions comprising Cajanus and glucosamine as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
Claims24
A composition comprising Cajanus or its bioactive constituents compound A-H and glucosamine.
Use of Cajanus for enhancing the anti-inflammatory activity of glucosamine.
Method of enhancing the efficacy of Cajanus which comprises adding to a composition containing Cajanus an effective amount of glucosamine.
Dependencies are inferred from the claim text.